iSGLT2 inhibitor

· Eurofarma Laboratorios S.A.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for iSGLT2 inhibitor, covering 2025-12-18 to 2025-12-18. Get the full timeline:

Most recent: Clinical Trial Update: iSGLT2 Inhibitor and a iDPP -4 Inhibitor in Treatment of Type 2 Diabetes Mellitus in Patients Treated With Metformin (TRIAD) [Phase 3]

See pricing